Clinical Trials
13 trialsNCT04700124 2026-02-05
KEYNOTE-B15
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT06305767 2026-01-13
INTerpath-005
Merck Sharp & Dohme LLC
Phase 1/2 Active not recruiting
NCT03978624 2025-10-15
Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT06427824 2025-10-03
Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
University of Chicago
Phase NA Recruiting
NCT03924856 2025-08-28
KEYNOTE-866
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT03924895 2025-08-28
KEYNOTE-905
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT00938145 2025-04-11
3 Tesla MRI in Patients With Bladder Cancer
University of Cincinnati
Phase NA Active not recruiting
NCT05082818 2022-06-14
Outcome of Treating Bladder Cancer in Sohag University Hospital
Sohag University
Completed
NCT04718948 2022-05-09
Multimodal Spectroscopy to Detect Urothelial Cancer in Urine
University of Florence
Unknown
NCT04588168 2020-10-19
Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase NA Recruiting
NCT00045630 2013-05-27
S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium
SWOG Cancer Research Network
Phase 2 Completed
NCT00003824 2012-03-09
S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
SWOG Cancer Research Network
Phase 3 Terminated
NCT00003640 2012-03-06
Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated